This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Bone Metabolism Therapeutics Market To 2018 - Hyperparathyroidism Sector To Decline In The Absence Of New Product Launches And Increased Generic Erosion For Zemplar, Hectorol And Sensipar

Table 53: Bone Metastases Therapeutics Market, Global, Revenue ($m), 2002-2010 61

Table 54: Bone Metastases Therapeutics Market, Global, Revenue Forecasts ($m), 2010-2018 61

Table 55: Bone Metastases Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2002-2010 62

Table 56: Bone Metastases Therapeutics Market, Global, Revenue Analysis by Geography ($m), 2010-2018 63

Table 57: Bone Metastases Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2010 65

Table 58: Bone Metastases Therapeutics Market, Global, Annual Cost of Treatment ($), 2010-2018 65

Table 59: Bone Metastases Therapeutics Market, Global, Treatment Usage Patterns (thousands), 2002-2010 66

Table 60: Bone Metastases Therapeutics Market, Global, Treatment Usage Patterns (thousands), 2010-2018 67

Table 61: Bone Metabolism Therapeutics Market, Global, Pipeline Analysis, NDA-filed Molecules,2011 72

Table 62: Bone Metabolism Therapeutics Market, Global, Pipeline Analysis, Phase III Molecules,2011 73

Table 63: Bone Metabolism Therapeutics Market, Global, Pipeline Analysis, Phase II Molecules,2011 78

Table 64: Bone Metabolism Therapeutics Market, Global, Pipeline Analysis, Phase I Molecules,2011 80

Table 65: Bone Metabolism Therapeutics Market, Global, Pipeline Analysis, Preclinical Phase Molecules,2011 81

Table 66: Bone Metabolism Therapeutics Market, Global, Pipeline Analysis, Discovery Phase Molecules,2011 82

Table 67: Bone Metabolism Therapeutics Market, Global, M&A, 2009-2011 96

Table 68: Bone Metabolism Therapeutics Market, M&A Deals, by Value ($m) 2009-2011 98

Table 69: Bone Metabolism Therapeutics Market, Co-development, by Geography, 2009-2011 100

Table 70: Bone Metabolism Therapeutics Market, Licensing Deals, by Geography, 2009-2011 102

 

 

 

List of Figures

 

Figure 1: Bone Metabolism Therapeutics Market, Global, Revenue Forecasts ($bn), 2002-2018 12

Figure 2: Bone Metabolism Therapeutics Market, Global, Annual Cost of Treatment ($), 2002-2018 13

Figure 3: Bone Metabolism Therapeutics Market, Global, Treatment Usage Patterns (millions), 2002-2018 14

Figure 4: Bone Metabolism Therapeutics Market, Global, Revenue Analysis by Geography ($bn), 2002-2018 16

Figure 5: Bone Metabolism Therapeutics Market, The US, Revenue Forecasts ($bn), 2002-2018 18

7 of 10

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs